 |
Antisense oligonucleotide targeted to the huntingtin protein |
|---|---|
| Trade Name | |
| Orphan Indication | Huntington disease |
| USA Market Approval | USA |
| USA Designation Date | 2015-12-29 00:00:00 |
| Sponsor | Isis Pharmaceuticals, Inc.;2855 Gazelle Court;Carlsbad, California, 92010 |
Related Access Program